![]() |
![]() |
Your cart is empty |
||
Books > Medicine > Clinical & internal medicine > Cardiovascular medicine
Interstitial lung disease (ILD) is a broad category of lung diseases that includes more than 150 disorders characterized by scarring or fibrosis of the lungs. In Pulmonary Arterial Hypertension and Interstitial Lung Disease: A Clinical Guide, renowned experts provide a state-of-the-art overview of the problems seen by physicians in the clinical management of ILDs. Divided into two sections, the first part provides and update on general issues and introduces both interstitial lung disease and associated pulmonary hypertension. A detailed analysis of the pathology of the various interstitial lung diseases is also provided. The second part addresses specific categories of disease. Bronchiolitis, hypersensitivity pneumonitis, and other conditions are covered, and the use of inspiratory and expiratory high resolution CT scan is discussed as well. This important new text is an invaluable resource for the practicing physician who must be aware of the broad and troubling manifestations of interstitial lung disease.
Together, the volumes in this series present all of the data needed at various length scales for a multidisciplinary approach to modeling and simulation of flows in the cardiovascular and ventilatory systems, especially multiscale modeling and coupled simulations. The cardiovascular and respiratory systems are tightly coupled, as their primary function is to supply oxygen to and remove carbon dioxide from the body's cells. Because physiological conduits have deformable and reactive walls, macroscopic flow behavior and prediction must be coupled to nano- and microscopic events in a corrector scheme of regulated mechanism. Therefore, investigation of flows of blood and air in anatomical conduits requires an understanding of the biology, chemistry, and physics of these systems together with the mathematical tools to describe their functioning in quantitative terms. The present volume focuses on macroscopic aspects of the cardiovascular and respiratory systems in pathological conditions, i.e., diseases of the cardiac pump, blood vessels, and airways, as well as their treatments. Only diseases that have a mechanical origin or are associated with mechanical disorders are covered. Local flow disturbances can trigger pathophysiological processes or, conversely, result from diseases of conduit walls or their environment. The ability to model these phenomena is essential to the development and manufacturing of medical devices, which incorporate a stage of numerical tests in addition to experimental procedures.
This book presents a collection of expert reviews on different subcellular compartments of the cardiomyocyte, addressing fundamental questions such as how these compartments are assembled during development, how they are changed in and by disease and which signaling pathways have been implicated in these processes so far. As such, it offers the first overview of the cell biology of heart disease of its kind, addressing the needs of cell biology students specializing in vascular and cardiac biology, as well as those of cardiologists and researchers in the field of cell biology.
Heart failure incidence increases with age and because the oldest segment of the population in Western countries is the fastest growing, the prevalence of heart failure is expected to increase. Understanding the signs and symptoms of heart failure is therefore of increasing necessity for physicians. Hemodynamic monitoring provides data on blood flow and pressure to assist physicians in determining the status of the patient's heart and in managing heart failure. This issue provides a detailed picture of the various options for assessing hemodynamics, including clinical assessment, echocardiography, transthoracic impedance cardiography, pulmonary artery catheters, B-type natriuretic peptide levels, and implantable devices.
Atrial fibrillation (AF) is the most common sustained arrhythmia, affecting approximately 2.3 million people in the US. One of the most serious side effects of AF is embolic stroke. Technology developed in the last 10 years has made AF treatable and potentially curable. This issue discusses many of the clinical issues in the management of AF, including cardioversion, anticoagulation, and ablation. Also included are current guidelines for treatment and a view of the future.
This book synthesizes the major research advances in molecular, biochemical and translational aspects of aging and heart failure over the last four decades and addresses future directions in management and drug discovery. It presents clinical issues and molecular mechanisms related to heart failure, including the changing demographics in the aging population with heart failure; hypertension and prevention of diastolic heart failure in the aging population; polypharmacy and adverse drug reactions in the aging population with heart failure; changes in the heart that accompany advancing age from humans to molecules; aging-associated alterations in myocardial inflammation and fibrosis and aging-related changes in mitochondrial function and implications for heart failure therapy. The book succinctly summarizes the large volume of data on these key topics and highlights novel pathways that need to be explored. Featuring contributions from leading clinician-scientists, Aging and Heart Failure: Mechanisms and Management is an authoritative resource on the major clinical issues in heart failure therapy in the elderly for cardiologists, gerontologists and internists.
Understanding how angiogenesis "works" and how to control it will
have massive implications on the management, treatments, and
ultimately the prevention of many common (and not so common)
diseases. Angiogenesis is the growth of new blood vessels and is an
important natural process in the body. A healthy body maintains a
perfect balance of angiogenesis modulators. In many serious disease
states, however, the body loses control over angiogenesis. Diseases
that are angiogenesis-dependent result when blood vessels either
grow excessively or insufficiently.
Angiogenesis is the growth of new blood vessels and is an important
natural process in the body. A healthy body maintains a perfect
balance of angiogenesis modulators. In many serious disease states,
however, the body loses control over angiogenesis. Diseases that
are angiogenesis-dependent result when blood vessels either grow
excessively or insufficiently. Understanding how angiogenesis
"works" and how to control it, will have massive implications on
the management, treatments, and ultimately the prevention of many
common (and not so common) diseases.
Angiogenesis is the growth of new blood vessels and is an important
natural process in the body. A healthy body maintains a perfect
balance of angiogenesis modulators. In many serious disease states,
however, the body loses control over antiogenesis. Diseases that
are angiogensis-dependent result when blood vessels either grow
excessively or insufficiently.
Angiogenesis is a multi-stage process that drives the generation of new blood and lymphatic vessels from pre-existing ones. It is highly active during embryogenesis, largely inactive during adulthood but reactivated during wound healing and under a number of pathological conditions including cancer and ocular diseases. In addition to endothelial cells, which line the walls of the vessels, several other cell types (pericytes, macrophages, progenitor cells ) also contribute to angiogenesis. A number of signaling pathways are activated and very finely tune the delicate morphogenetic events that ultimately lead to the formation of stable blood proof neovessels. This book reviews recent advances in our understanding of the molecular and cellular mechanisms of angiogenesis, with a focus on how to integrate these observations into the context of developmental, post-natal and pathological neovascularization. The book was published under the auspices of the French Angiogenesis Society. Most contributors are prominent members of this Society or international researchers who have actively contributed to the Annual Meetings of the Society."
This comprehensive reference textbook examines in detail physiological and pathophysiological aspects of the cardiovascular system and cardiovascular disease in the sporting population. In the first part of the book, the non-invasive and invasive diagnostic techniques employed in cardiology are systematically reviewed, with explanation of their indications and clinical utility. The second, more extensive part is devoted to clinical cardiology and covers the great majority of cardiological problems encountered among athletes and other sportsmen and -women. Syncope, cardiac arrhythmias, and sudden cardiac death are extensively addressed, and guidance is provided on sports practice for individuals with different forms of heart disease. Cardiologic rehabilitation is discussed, and attention is also paid to the legal implications of diagnosed or unsuspected cardiovascular diseases for sportspeople. Sports Cardiology will be an invaluable resource for trainee and experienced health care professionals, including in particular cardiologists and sports medicine physicians. It will provide the knowledge required in order to make critical decisions regarding eligibility, thereby preventing tragic events and especially sudden death -- the most devastating occurrence in sport.
Written by an eminent cardiovascular physiologist with a strong track record in dealing with issues related to exercise and environmental physiology, this text covers cardiovascular function from the exercise and human physiologist's viewpoint. It provides a solid foundation of knowledge of how the cardiovascular system responds and adapts to the challenges of exercise and environmental change, and analyses the practicalities of measuring cardiovascular parameters in normal human subjects. Case studies in exercise physiology throughout text. Open-ended questions at end of each chapter encourage students to explore common situations facing exercise and human physiologists. Bibliography at end of each chapter directs students to further reading resources. Summaries at start of each chapter and multiple choice questions with explanatory answers at end of book aid revision and help students test their knowledge.
This volume is the fourth in a series on quantitative coronary arteriography (QCA) published over the last seven years. Every two years the advances in this exciting field are presented by their leading experts. There is a significant growth in this field which has translated into the increasing sizes of the volumes published over the years. In addition to covering the developments in the more traditional items such as QCA and other modalities, and coronary blood flow and flow reserve, the following subjects have been emphasized in this particular volume: quality control in QCA; QCA in the major regression/progression trials; QCA in the major restenoisis studies; QCA after recanalization techniques; and QCA and infracoronary prostheses. In addition, an extensive overview is given of ZCA equipment and technical requirements. The book provides a comprehensive, overview for all clinicians and physicists actively involved or otherwise interested in the developments in quantitative coronary arteriography.
Experimental and clinical evidence supports the view that the activation of the renin angiotensin aldosterone system is involved in cardiovascular pathology including hypertension, heart failure, myocardial ischemia, and atherosclerosis. The present volume describes the intricacies involved in these processes, including the in?uence of prorenin/renin, angiotensin II, angiotensin (1-7), and aldosterone on cardiac and vascular functions as well as their involvement in the generation of cardiovascular diseases. Fundamental aspects like intracellular signaling, regulation of cell volume in the failing heart, and the presence of an intracrine renin angiotensin system are discussed. Moreover, the role of the mineralocorticoid receptor as an important c- ponent of the intracrine renin angiotensin system and as a regulator of extracellular action of angiotensin II is described, reinforcing the view that aldosterone inhibitors are helpful in the treatment of heart failure and hypertension. Let us hope the imp- tant topics included here motivate basic and clinical investigators and contribute to the development of new therapeutic approaches for cardiovascular diseases. We want to thank the distinguished authors and Humana Press for the opportunity to publish this important book. Walmor C. DeMello Edward Frohlich v Contents 1 Systemic Versus Local Renin Angiotensin Systems. An Overview ...1 Walmor C. DeMello and Richard N. Re 2 Clinical Import of the Local Renin Angiotensin Aldosterone Systems ...7 Edward D. Frohlich 3 Renin, Prorenin, and the (Pro)Renin Receptor ...15 Genevieve Nguyen and Aurelie Contrepas 4 Local Renin Angiotensin Systems in the Cardiovascular System ...25 Richard N.
This book presents the latest findings in the field of research of mechanosensitivity and mechanotransduction in different cells and tissues. Mechanosensitivity and mechanotransduction of the heart and vascular cells, in the lung, in bone and joint tissues, in sensor systems and in blood cells are described in detail. This Volume focuses on molecular mechanisms of mechanosensitivity and mechanotransduction via cytoskeleton. Integrin-mediated mechanotransduction, the role of actin cytoskeleton and the role of other cytoskeletal elements are discussed. It contains a detailed description of several stretch-induced signaling cascades with multiple levels of crosstalk between different pathways. It contains a description of the role of nitric oxide in regulation of cardiac activity and in regulation of mechanically gated channels in the heart. In the heart mechanical signals are propagated into the intracellular space primarily via integrin-linked complexes, and are subsequently transmitted from cell to cell via paracrine signaling. Biochemical signals derived from mechanical stimuli activate both acute phosphorylation of signaling cascades, such as in the PI3K, FAK, and ILK pathways, and long-term morphological modii cations via intracellular cytoskeletal reorganization and extracellular matrix remodelling. Cellular and molecular effects of mechanical stretch on vascular cells are also discussed. This Volume highlights the role of mechanotransduction in the lung, in bone and joint tissues. For the first time mechanosensitivity and mechanotransduction in blood cells are discussed. It contains new insights into mechanosensitive K+ channels functioning in mouse B lymphocytes. This book is a unique collection of reviews outlining current knowledge and future developments in this rapidly growing field. Currently, investigations of the molecular mechanisms of mechanosensitivity and mechanotransduction are focused on several issues. The majority of studies investigate intracellular signaling pathways. Knowledge of the mechanisms which underlie these processes is necessary for understanding of the normal functioning of different organs and tissues and allows to predict changes, which arise due to alterations of their environment. Possibly such knowledge will allow the development of new methods of artificial intervention and therapies. This book brings up the problem closer to the experts in related medical and biological sciences as well as practicing doctors besides just presenting the latest achievements in the field.
Cardiovascular MR imaging has become a robust, clinically useful mod- ity, and the rapid pace of innovation and important information it conveys have attracted many students whose goal is to become adept practitioners. In turn, many excellent textbooks have been written to aid this process. These books are necessary and useful in helping the student learn the underlying pulse sequences used in CMR, as well as the imaging findings in a variety of disorders. However, one of the difficulties inherent in learning CMR from a book is that the printed format is not the ideal medium to d- play the dynamic imaging that comprises a typical CMR case. For instance, it may be difficult to perceive focal areas of wall motion abnormality on serial static pictures, but these abnormalities are often easily seen on cine loops. One might say that trying to learn CMR solely from a standard textbook with illustrations is like trying to learn to drive by looking at snapshots obtained through the windshield of a moving car. The learner needs to see the cardiac motion and decide if it is normal or abnormal; he or she needs to be in the driver's seat. An additional limitation of the ava- able textbooks on CMR is that while they often have superb illustrations of abnormal findings, these images have been preselected.
This book focuses on how ventricular assist devices (VADs) can help provide destination therapy for patients with terminal heart failure, one of the most serious diseases in the world today because of the tremendous number of patients, the high mortality rate, and the cost of care. One means of providing cardiological support for patients suffering from heart failure is with VADs, and more than 10,000 patients worldwide have now been implanted with these devices. Half of them already have lived more than one year, and 2,000 patients more than two years, after surgery. This improved survival means that we have reached a point where VADs can be used for destination therapy, not just for bridge-to-recovery or bridge-to-transplant. In view of the increasing number of patients with advanced-stage heart failure and the availability and longevity of transplanted hearts, VADs can solve many problems. In addition to providing information about the devices themselves, this book includes vital guidelines on long-term management and support of VAD-implanted patients' everyday lives.
The present book reveals the importance of preventive medicine in cardiology and public health, addressing the lack of a broad discussion of this topic in the current literature. It examines the most important risk factors for different cardiovascular diseases, discussing them in detail from a clinical standpoint and presenting important information from a preventive medicine perspective. Further, specific chapters discuss the burden of cardiologic risk factors in special contexts, such as in women, child and adolescents, and in low-income populations. Lastly, a number of conditions that are often overlooked in terms of their cardiological impact are discussed, such as Chagas disease, rheumatic cardiomyopathy and post-traumatic stress disorder. Cardiovascular diseases are still the major cause of death in the world, even though they are considered preventable clinical conditions. The increased prevalence of some risk factors for cardiovascular diseases is an important concern for cardiologists around the world. On the other hand, primary prevention programs have proven their efficacy concerning some known and treatable risk factors, such as with hypercholesterolemia, hypertension, diabetes and smoking, but still need to be made more of a priority in public health. Prevention of Cardiovascular Diseases is a book intended for multi-disciplinary audience and aimed for all professionals who are willing to face the challenge of cardiovascular prevention
This book will provide both an evidence base and practical recommendations for the treatment of patients with congenital heart disease. It will be a resource to all health care providers, including pediatric cardiologists, pediatric intensivists, pediatric heart surgeons, fetal specialists, maternal fetal medicine specialists, neonatologists, nurses, advanced practice nurses, in addition to trainees in the field. It will summarize world knowledge on the topic of heart failure in patients with congenital heart disease. It will provide an in depth analysis of the current methods of diagnosis and treatment of heart failure. Now that surgical results are at record success rates, more patients with congenital heart disease are surviving, and thus at risk for sequelae from their disease, including heart failure. It will provide evidence based and practical recommendations to the practitioner for the management of heart failure signs and symptoms.
The second edition of this work continues to address the intimate pathophysiologic relationship between hypertension and stroke. The editors and authors clearly and concisely synthesize our developing knowledge of this relationship and place epidemiologic and physiologic information into a practical clinical context. Comprehensive chapters present the evidence supporting strategies for stroke prevention and care, including blood pressure lowering therapies, anti-coagulation, and management of other cerebrovascular risk factors. In addition to prescriptive measures for first stroke prevention, the book illuminates current regimens for care immediately after acute stroke and for the prevention of recurrent stroke. This latest edition also features extensively updated chapters from the previous edition, as well as new chapters on the effects of hypertension and stroke on the cerebral vasculature, blood pressure management in subarachnoid hemorrhage, and blood pressure variability, antihypertensive therapy, and stroke risk. Written by experts in the field, Hypertension and Stroke: Pathophysiology and Management, Second Edition is of great utility for specialists in neurology and cardiovascular medicine and a valuable practical resource for all physicians caring for older adults and hypertensive patients.
This book analyzes the internal and external causes of acquired and familiar venous thrombosis and proposes the origins and onset of venous thrombus diseases and their triggering factors. It discusses venous and arterial thrombus in two parts, each starting from the genomics and the findings of immunocytological research conducted in a variety of clinical groups and on different experimental models and revealing the mechanisms behind the development of thrombotic diseases and the pathogenesis processes. Further, the book describes the clinical manifestation and the nature of the diseases. The book offers valuable insights important in the prevention and treatment of thrombotic disease.
One of the only books discussing new advances in venous ulcer
therapy, "Venous Ulcers" provides a comprehensive look at the
molecular biology and pathophysiology of venous ulcers. It
discusses the many new treatments currently being used that offer
non-invasive treatment options to patients with venous ulcerations.
Pathological heart rhythms are a major health issue. In this book experts from various fields provide an important context for understanding the complicated molecular and cellular mechanisms that underlie normal and pathophysiological cardiac rhythms. Individual chapters cover a full range of topics, including the ionic basis of pacemaking, the role of specific channels and transporters in sinoatrial node pacemaking, altered intracellular Ca2+ handling in response to disease, computer modeling of the action potentials of pacemaker and working cardiomyocytes, genetic and molecular basis of inherited arrhythmias and a review of established and novel antiarrhythmic agents. Due to the key importance of the specialized pacemaker cells and tissue (sinoatrial and atrioventricular nodes) in maintaining heart rate and rhythm, special emphasis is placed on the peculiar electrophysiology of these cells.
A modern definition of health goes beyond the biological dimension to encompass human functionality and well-being. Quality of life is one of the most popular health-related concepts and simultaneously reflects several dimensions of individual health. Health-related quality of life (HRQoL) is taken to include physical, psychological, and social aspects of positive well-being as well as negative effects of illness, treatment, and infirmity. Quality of life outcomes are now considered an important indicator of the success of both diagnostic and therapeutic procedures. In this book, recognized experts discuss the findings of various studies, including their own, regarding HRQoL in patients with cardiovascular diseases. The impact of the newest forms of medical treatment on well-being is considered in patients with arterial hypertension, coronary artery disease, heart failure, arrhythmias, and stroke as well as in patients who have undergone interventional procedures or have implantable cardiac devices. By summarizing established facts and presenting new data, this book will be an invaluable source of information for all practitioners in the field. |
![]() ![]() You may like...
Computer-Aided Vaccine Design
Joo Chuan Tong, Shoba Ranganathan
Hardcover
R3,252
Discovery Miles 32 520
Nonlinear Wave and Plasma Structures in…
Evgeny Mishin, Anatoly Streltsov
Paperback
R3,556
Discovery Miles 35 560
Child Maltreatment in Residential Care…
Adrian V. Rus, Sheri R. Parris, …
Hardcover
R5,609
Discovery Miles 56 090
|